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Abstract. 
 
Involucrin is synthesized in abundance dur-
ing terminal differentiation of keratinocytes. Involucrin
is a substrate for transglutaminase and one of the pre-
cursors of the cross-linked envelopes present in the cor-
neocytes of the epidermis and other stratiﬁed squa-
mous epithelia. These envelopes make an important
contribution to the physical resistance of the epidermis.
We have generated mice lacking involucrin from em-
bryonic stem cells whose involucrin gene had been ab-
lated by homologous recombination. These mice devel-
oped normally, possessed apparently normal epidermis
and hair follicles, and made corniﬁed envelopes that
could not be distinguished from those of wild-type
mice. No compensatory increase of mRNA for other
envelope precursors was observed.
Key words: embryonic stem cells • envelopes • skin
morphology • skin resistance • involucrin
 
Introduction
 
The protective function of the mammalian epidermis de-
pends largely on the presence of the chemically resistant
envelope of the corneocytes. The envelope consists of pro-
teins stabilized by 
 
e
 
(
 
g
 
-glutamyl)lysine cross-links formed
under the action of transglutaminase 1, an enzyme spe-
cific to keratinocytes (Rice and Green, 1978; Simon and
Green, 1985; Thacher and Rice, 1985). The protein enve-
 
lope is covered with a monomolecular layer of 
 
N
 
-(
 
v
 
-
hydroxyacyl)sphingosine bound to protein by ester bonds
(Swartzendruber et al., 1987; Wertz and Downing, 1987;
Marekov and Steinert, 1998).
Involucrin is synthesized in the outer living layers of ter-
minally differentiating keratinocytes of all stratified squa-
mous epithelia (Banks-Schlegel and Green, 1981). Human
involucrin has been shown to be a preferred substrate of
keratinocyte transglutaminase and a precursor of the
cross-linked envelope (Rice and Green, 1979; Eckert et
al., 1993; Yaffe et al., 1993). Expression of human involu-
crin in transgenic mice results in abnormalities of the skin
and hair (Crish et al., 1993).
The nucleotide sequence of the involucrin gene has
been determined in a large number of anthropoid and
nonanthropoid mammals. In all species examined, the
coding region of the gene contains a segment of short tan-
dem repeats, which accounts for one half to two thirds of
the coding region. The entire involucrin molecule, and
particularly its segment of repeats, contains numerous
glutamine residues (Eckert and Green, 1986), clearly re-
lating to the function of the protein as an amine acceptor
in transglutaminase-catalyzed cross-linking (Tseng and
Green, 1988, 1990; Phillips et al., 1990, 1997; Djian and
Green, 1991; Djian et al., 1993).
Other precursors of the cross-linked envelope are lori-
crin (Mehrel et al., 1990), the small proline-rich proteins
(SPRRs)
 
1
 
 (Kartasova and van de Putte, 1988), and two
membrane-bound proteins, periplakin and envoplakin (Si-
mon and Green, 1984; Ruhrberg et al., 1996, 1997). Re-
cently, additional envelope constituents including S100
proteins have been described (Robinson et al., 1997).
Whereas the role of transglutaminase 1 in the synthesis of
the cornified envelope is clear (Jeon et al., 1998), the rela-
tive importance of the various substrates has not been es-
tablished. Therefore, we decided to generate mice lacking
involucrin by targeted ablation of the gene. Surprisingly,
the absence of involucrin had no obvious effect on the
cornified envelope, the morphology of the epidermis, or
the hair follicles.
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ES, embryonic stem; SPRR, small pro-
line-rich protein. 
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Materials and Methods
 
Construction of the Targeting Vector
 
The whole involucrin coding region, which is confined to a single exon, was
replaced with a neomycin phosphotransferase gene. We had isolated previ-
ously the involucrin genes of the NIH Swiss and BALB/c mice (Djian et al.,
1993). To transform J1 embryonic stem (ES) cells, which are derived from
a male agouti 129/SV mouse (Li et al., 1992), with isogenic DNA, we iso-
lated the involucrin gene of a 129/SV mouse genomic library in the 
 
l
 
FIXII
vector (Stratagene). Screening of 10
 
6
 
 phage DNA plaques (Sambrook et
al., 1989) with a 1.2-kb HindIII fragment containing most of the involucrin
coding region identified two positive clones, of which clone 
 
l
 
17B was used
to prepare the targeting vector. This clone contained the coding region
flanked by 1.5 kb of upstream sequence and 11.5 kb of downstream se-
quence. The entire insert of 
 
l
 
1
 
7B was excised with Not1 (whose site is
present in the 
 
l
 
FIXII vector, on both sides of the insert) and subcloned
into pBluescript. The resulting plasmid (psv6) was cut with Not1, Xba1,
and Pst1 to excise most of the coding region and to subclone the flanking
sequences. These sequences were isolated as a 1.7-kb Not1–Pst1 fragment
(upstream) and a 10.6-kb Xba1–Not1 fragment (downstream), thus gener-
ating psv18 and psv26, respectively. Since psv18 retained 95 codons, in-
cluding the initiator ATG, and since we were not certain that the encoded
peptide could not act as a substrate in transglutaminase-catalyzed cross-
linking, we deleted those codons with BAL31. The resulting clones were
sequenced and one clone (psv23) was used in subsequent experiments; it
lacked the entire coding region, the 3
 
9
 
 splice site, and a small 3
 
9
 
 part of the
intron (see Fig. 1). The neomycin phosphotransferase gene under the con-
trol of the phosphoglucokinase promoter and followed by the phosphoglu-
cokinase 3
 
9
 
 end, including the polyA addition site, was excised from pGK-
neo (a gift from Dr. Fred Alt, Children’s Hospital, Boston, MA) with
EcoR1 and HindIII. An Xho1 site was added immediately 3
 
9
 
 of the HindIII
site by subcloning the EcoR1–HindIII fragment into pBluescript and reex-
cising it with EcoR1 and XhoI. The resulting fragment was cloned directly
into the linker of psv23, in the right orientation and downstream of the in-
volucrin 5
 
9
 
 sequence. The insert of the resulting plasmid was excised with
Not1 and Xho1, blunt-ended with the Klenow fragment, and cloned with
Xba1 linkers upstream of the Xba1–Not1 insert of psv26. The sequence
flanking the Xba site of the linkers was such as to regenerate the Not1 site
that had been partially abolished by treatment with the Klenow enzyme.
The orientation of the Xba insert in the clones obtained was determined,
and one of the constructs, psv29, was used to transfect ES cells. To facilitate
homologous recombination, we excised the insert with Not1 and removed
the pieces of linker on both ends by a brief treatment with BAL31, before
transfection of the ES cells.
 
Transfection and Selection of ES Cells
 
The J1 ES cell line was cultivated on a feeder layer of irradiated embry-
onic fibroblasts (6,000 rads). The fibroblasts were prepared from day 14
 
mouse embryos homozygous for the neomycin resistance gene. ES cells
were grown in bicarbonate buffered DMEM supplemented with 15% FCS
(heat inactivated at 56
 
8
 
C for 30 min), nonessential amino acids, 500 U/ml
of murine leukemia inhibitory factor (ESGRO; GIBCO BRL), penicillin,
streptomycin, and 0.11 mM 2-mercaptoethanol. For electroporation of
DNA, ES cells were trypsinized, washed with electroporation buffer, and
resuspended at 2 
 
3 
 
10
 
7
 
 cells/ml. The cells were mixed with 120 
 
m
 
g of DNA
and electroporated at 0.4 kV and 25 
 
m
 
F, at room temperature, using a
gene pulser apparatus (Bio-Rad Laboratories). After electroporation, the
cells were cooled on ice for 10 min, and then plated on a feeder layer. Af-
ter 24 h, the transfectants were selected in the presence of 0.4 mg/ml of
G418 (GIBCO BRL). After 9 d of selection, individual drug-resistant
clones were picked and transferred to 96-well plates. When the cells were
about half confluent, they were trypsinized; half was left in the well and
frozen at 
 
2
 
120
 
8
 
C in the presence of 20% DMSO, whereas the remaining
half was transferred to 24-well plates,
 
 
 
for screening by Southern blotting.
Positive clones were injected into BALB/c and C57BL/6 blastocysts at the
Brigham and Women’s Hospital Core Transgenic Mouse Facility, Boston,
MA (by Dr. Arlene Sharpe).
 
Southern Blot Analysis 
 
DNA was prepared from ES cells or mouse tails by lysis in the presence of
100 mM Tris-HCl, pH 8.5, 200 mM NaCl, 5 mM EDTA, 0.2% SDS, and
0.1 mg/ml proteinase K. The lysate was incubated at 55
 
8
 
C for at least 6 h,
and the DNA was precipitated in the presence of isopropanol, spooled
out, and resuspended in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA (Laird et
al., 1991). Southern blots were performed as described in Tseng and
Green (1988). The probe was a 1.0-kb PstI–HindIII fragment located im-
mediately 5
 
9
 
 to the genomic fragment used to prepare the targeting vector
(see Fig. 1). To clone the probe, we first constructed a library from size-
fractionated genomic DNA. After digestion with Pst1 and electrophoresis
of the digest, fragments of 
 
z
 
2.6 kb were excised from the agarose gel and
ligated to pBluescript. The ampicillin-resistant bacteria were divided into
22 pools, each containing 
 
z
 
7,000 primary transformants. Screening by
Southern blotting with the 1.25-kb Not1–Pst1 fragment located immedi-
ately upstream of the involucrin coding region revealed two positive
pools. The fragment of interest was amplified by PCR, using an upstream
primer located in the plasmid, and a downstream primer corresponding to
codons 2–8 of the involucrin gene. The PCR product was cut with Pst1 and
Hind III and the mixture of fragments was ligated directly into pGEM3z
cut with PstI and HindIII. All recombinants obtained contained the frag-
ment of interest (psv35).
 
Northern Blot Analysis
 
For preparation of total skin RNA, mice were first anesthetized by intra-
peritoneal injection of tribromoethanol (Sigma-Aldrich). Hairy mice were
depilated with a commercial preparation containing thioglycolic acid. The
skin was then removed, frozen immediately in liquid nitrogen, pulverized in
Figure 1. Ablation of the in-
volucrin gene. Diagram of
the involucrin locus, the re-
placement construct, and the
resulting recombined locus.
Distances between restric-
tion sites are given in kilo-
bases. The three boxes rep-
resent the involucrin coding
region (stippled), the neo-
mycin phosphotransferase
gene (dotted), and the
probes (psv35 and psv18)
used for screening ES cells
and mice (solid). psv35 used
in conjunction with either
EcoR1 or Pst1 identifies un-
ambiguously the recombined
locus, since it hybridizes to
specific fragments of 3.45 kb
(EcoR1) and 2.15 kb (Pst1); the corresponding fragments derived from the natural locus are 11.0 and 2.6 kb, respectively. Psv 18,
which hybridizes to the construct itself, was used to demonstrate that transgenic mice did not contain additional copies of the construct
inserted by nonhomologous recombination. E, EcoR1; H, HindIII; N, Not1; P, Pst1; X, Xba1. 
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a mortar, resuspended in Tripure isolation reagent, and purified according
to the manufacturer’s recommendation (Boehringer). Total RNA was ana-
lyzed by electrophoresis in agarose gels containing formaldehyde, according
to Sambrook et al. (1989), and RNA was transferred to nylon without prior
treatment of the gel. Prehybridization, hybridization, and washing condi-
tions were exactly as those described for Southern blotting. The probes con-
sisted of a 1.2-kb fragment containing most of the involucrin coding region
(Djian et al., 1993), a 0.9-kb BamHI–PstI fragment containing the 3
 
9
 
 half of
the loricrin coding region (Mehrel et al., 1990), and a 0.7-kb EcoR1 frag-
ment derived from the SPRR1 cDNA (Kartasova et al., 1996).
 
Western Blot Analysis
 
Protein extracts containing involucrin were prepared from mouse skin.
Pulverized skin was prepared as described above for RNA. Approxi-
mately 400 mg of tissue was resuspended in 2 ml of a buffer containing 50
mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM EDTA, 0.1 mM leupeptin,
0.01 mM pepstatin, and 1 mM PMSF. The tissue was homogenized (Potter
Elvekjem), clarified by two centrifugations at 120 
 
g
 
 for 15 min and 48,000 
 
g
 
for 30 min, and the supernatant was collected. The protein concentration
of the supernatant was determined with a protein assay kit using IgG as
 
standards (Bio-Rad Laboratories). Protein extracts were stored at 4
 
8
 
C in
the presence of 1% SDS. Partially purified mouse involucrin was prepared
according to Etoh et al. (1986).
The proteins were resolved by SDS-PAGE, using 4 and 6% acrylamide
plus bisacrylamide for the stacking and resolving gels, respectively (a ratio
of 29:1 for both stacking and resolving gel). Immunoblot analysis was car-
ried out according to Kahlem et al. (1998). The antiinvolucrin (Djian et al.,
1993) and the secondary antibody were both added at a 1:4,000 dilution.
 
Histological Analysis and Preparation of
Cornified Envelopes
 
For sections stained with hematoxylin and eosin, the skin samples were
first fixed in 10% buffered formalin and embedded in paraffin then
stained. For immunofluorescence studies of involucrin, skin samples were
snap frozen in OCT (Miles) and isopentane and cut with a cryomicrotome
at 5 mm. Sections were fixed in acetone/methanol (1:1) at 
 
2
 
20
 
8
 
C and
stained with rabbit anti–mouse involucrin (Covance), then were detected
with goat antiserum to rabbit IgG coupled to Alexa 488 (Molecular
Probes). DNA was stained using Vectashield mounting medium contain-
ing DAPI (Vector Laboratories).
For preparation of envelopes, the tip of the ear was cut, placed in water
containing 25 mM DTT and 2% SDS, heated to 100
 
8
 
C for 15 min, and cen-
trifuged. The pellet was resuspended in 10 mM Tris-HCl, pH 8.0, and 1
mM EDTA. Envelopes were examined in a hemocytometer under phase
microscopy.
 
Results
 
Ablation of the Involucrin Gene
 
The entire coding region of the involucrin gene was re-
placed with the neomycin phosphotransferase gene. ES cells
were transformed with the construct and neomycin-resistant
clones were screened by Southern analysis, using psv35 as
probe (Fig. 1). Analysis of 297 neomycin-resistant clones
disclosed 3 in which the involucrin gene had been ablated by
homologous recombination (Fig. 2 A). All three clones
(D
 
2
 
D
 
2
 
, D
 
3
 
D
 
5
 
, and A
 
1
 
C
 
4
 
) were injected into C57BL/6 and
BALB/c blastocysts to generate chimeric animals. Chimeric
males derived from clone A
 
1
 
C
 
4 
 
were backcrossed with ei-
ther C57BL/6 or BALB/c females; both backcrosses yielded
progeny of which 70–80% were agouti. As expected, prob-
ing of a Pst1 digest of genomic DNA with psv35 showed that
agouti mice contained one ablated allele (2.15-kb fragment)
and one normal allele (2.6-kb fragment) (Fig. 2 A). Reprob-
ing of the same blot with psv18, which hybridizes to the con-
struct itself (Fig. 1), showed that heterozygous mice con-
tained no additional copy of a transgene that might have
inserted randomly by nonhomologous recombination. Het-
erozygous mice were intercrossed to generate mice homozy-
gous for the mutation. Absence of the involucrin coding re-
gion in the inv
 
2
 
/
 
2
 
 mice was confirmed by Southern blotting.
Absence of involucrin mRNA and protein in the skin was
confirmed by Northern and Western blot analyses (Fig. 2
B). Because nude mice have a thicker epidermis and more
involucrin than hairy mice, we transferred the ablated allele
to a nude background. 
 
nu/nu
 
 males (BALB/c) were crossed
with inv
 
2
 
/
 
2
 
 females (C57BL/6), thereby generating F1 prog-
eny that were inv
 
1
 
/
 
2
 
 and 
 
nu
 
/
 
1
 
. The F2 progeny of F1 inter-
crosses yielded 
 
nu/nu
 
, inv
 
2
 
/
 
2
 
 at the expected frequency of
1:16. Frozen sections of mouse skin (
 
nu/nu
 
, inv
 
2
 
/
 
2
 
 and 
 
nu/
nu
 
, inv
 
1
 
/
 
1
 
) were stained with a rabbit antiserum prepared
against recombinant involucrin (Covance). In the inv
 
1
 
/
 
1
 
mice, involucrin had the typical distribution in the outer
third to half of the living layers, in the stratum corneum, and
in the hair follicles; no involucrin was detected in the mice
lacking the involucrin gene (Fig. 3).
Figure 2. Southern, Northern, and Western blot analysis of wild-
type mice and mice lacking involucrin. (A) Southern hybridiza-
tion with psv35 of genomic DNA prepared from ES clones (top)
or mouse tails (bottom). Screening of DNA prepared from neo-
mycin-resistant clones and digested with either EcoR1 (top left)
or Pst1 (top right) identified three positive clones giving rise to
3.45- and 2.15-kb fragments (D2D2, D3D5, and A1C4); one nega-
tive clone is also shown (D1D2). Clone A1C4 was used to generate
chimeric males, which were backcrossed to produce heterozy-
gous progeny. Heterozygotes were then intercrossed, and the
progeny were genotyped with Pst1. One wild-type (1/1), one
heterozygote (1/2), and one inv2/2 mouse (all littermates) are
shown in the bottom panel. (B) Northern and Western blot anal-
yses of skin prepared from a wild-type and an inv2/2 mouse. The
inv2/2 mouse contains neither detectable involucrin mRNA
(left) nor the corresponding protein (right). W, whole protein ex-
tract; I, partially purified involucrin.  
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Mice Lacking Involucrin Develop and
Reproduce Normally
 
Whether produced from backcrosses with C57BL/6 or
BALB/c, the inv
 
2
 
/
 
2
 
 mice appeared normal and showed no
obvious difference from their heterozygous or wild-type
littermates. Inv
 
2
 
/
 
2
 
 females intercrossed with inv
 
2
 
/
 
2
 
 males
produced litters of normal size. Among the 177 offspring
examined from the heterozygous intercrosses, the num-
bers of wild-type, heterozygous, and inv
 
2
 
/
 
2
 
 mice were 54
(30.5%), 87 (49.2%), and 36 (20.3%), respectively, or close
to the expected Mendelian ratio of 0.25:0.5:0.25.
 
The Epidermis and Hair Follicles of Mice Lacking 
Involucrin Appear Histologically Normal
 
Histological sections of the back skin of adult wild-type
and mice lacking involucrin were compared. No differ-
ences were observed either in the epidermis or in the hair
follicles (Fig. 4, A and B). As mouse epidermis of the
trunk is very thin and contains only two to three layers, we
also examined epidermis of the tail, whose thickness is
comparable with that of the human epidermis, and which
possesses clearly distinguishable basal, spinous, granular,
and cornified layers. Neither in the spinous and granular
 
Figure 3.
 
Absence of involucrin from epi-
dermis of mice lacking involucrin by im-
munofluorescence. Frozen sections of
back skin of nude mice (
 
nu/nu
 
, inv
 
1
 
/
 
1
 
 and
 
nu/nu
 
, inv
 
2
 
/
 
2
 
) were reacted with a rabbit
antiserum prepared against the recombi-
nant protein. The secondary antibody was
conjugated to Alexa 488. (A) In the inv
 
1
 
/
 
1
 
mice, the epidermis is brightly stained for
involucrin in the outer living layers, the
stratum corneum, and the hair follicles.
(B) The epidermis of inv
 
2
 
/
 
2
 
 mice reveals
no involucrin staining. (C and D) The ad-
dition of the nuclear stain DAPI reveals
the nucleated cells of inv
 
1
 
/
 
1
 
 and inv
 
2
 
/
 
2
 
.
Bar, 50 
 
m
 
m.
Figure 4. Histological analysis of
skin of mice lacking involucrin.
Paraffin sections of back skin
whose epidermis contains only
two to three cell layers (A and
B) and tail skin (C–F) of C57BL/6
mice were stained with hematox-
ylin and eosin. Skin of the tail
contains many more cell layers
and includes clearly identifiable
basal, spinous, granular, and
cornified layers. The absence of
involucrin (B, D, and F) does not
result in detectable abnormali-
ties in either site. Bar, 50 mm. 
Djian et al. 
 
Mice Without Involucrin
 
385
 
layers, where free involucrin is found, nor in the stratum
corneum, where the involucrin is cross-linked in the enve-
lopes, was there a perceptible difference between wild-
type (Fig. 4, C and E) and inv
 
2
 
/
 
2
 
 (Fig. 4, D and F) litter-
mates. The healing time of the wounds resulting from the
skin biopsies used for histological analysis was compared
in mice lacking involucrin and normal mice and was not
found to be significantly longer in the former. The gross
appearance of the esophageal, conjunctival, and corneal
epithelia, which also contain involucrin, appeared un-
changed in its absence.
 
Mice Form Normal Cornified Envelopes in the Absence 
of Involucrin
 
Envelopes were prepared by removing the tips of ears of
inv
 
2
 
/
 
2
 
 and wild-type mice, heating them to 100
 
8
 
C for 10 min
in the presence of 2% SDS and 25 mM DTT, and examining
the envelopes by phase–contrast microscopy. The envelopes
prepared from inv
 
2
 
/
 
2
 
 mice were indistinguishable from
those of wild-type mice (Fig. 5). Both strains of mice pos-
sessed a mixture of balloon-shaped and angular envelopes.
Balloon-shaped envelopes probably originate from the out-
ermost corneocytes of the epidermis, which have lost their
desmosomes, whereas angular envelope are likely to have
originated from more internal corneocytes, which were still
attached to each other by the remains of desmosomes.
We compared the resistance of wild-type envelopes and
envelopes lacking involucrin to various physical and chemi-
cal agents. We tested the effects of sonication, detergents
(SDS, guanidine, and urea), proteases (trypsin and pronase),
and grinding with a motor-driven homogenizer. Although all
of these treatments caused progressive disruption of the en-
velopes, we could detect no difference in the resistance of
wild-type envelopes and envelopes lacking involucrin.
 
Absence of Involucrin Is Not Compensated by Increased 
Synthesis of Other Envelope Precursors
 
In view of the lack of any detectable phenotype produced
by the absence of involucrin, we thought that increasing
levels of other envelope precursor proteins might have
compensated for the absence of involucrin. The levels of
the mRNAs encoding loricrin (Mehrel et al., 1990) and
SPRR1 (Kartasova and van de Putte, 1988; Kartasova et
al., 1996) were found to be identical in the mice lacking in-
volucrin and in the wild-type mice (Fig. 6). Therefore, the
absence of involucrin is not compensated by increased lev-
els of either loricrin or SPRR1 mRNAs.
 
Discussion
 
Mutations in the human transglutaminase 1 gene result in
lamellar ichthyosis (Huber et al., 1995) due to the absence
of cross-linked envelopes (Jeon et al., 1998). Targeted dis-
ruption of the transglutaminase 1 gene in mice also causes
the absence of envelopes, a severe disruption in barrier
function, and early lethality (Matsuki et al., 1998). There-
fore, it is clear that the cornified envelope is essential for
the protective function of the epidermis, and that only
transglutaminase 1 is essential for the synthesis of the enve-
lope, since the other two transglutaminases present in kera-
tinocytes (types 2 and 3) do not compensate for its absence.
A large body of data supported the earlier conclusion
that involucrin was an essential component of the cross-
linked envelope. The synthesis of involucrin is tightly
regulated: it is restricted to terminally differentiated kera-
tinocytes of stratified squamous epithelia. Human involu-
crin is a preferred substrate of transglutaminase 1, since
after incubation of a crude extract of cultured epidermal
cells in the presence of labeled putrescine and trans-
glutaminase 1, involucrin was labeled at least 80 times
more intensely than the average of the other cytosolic pro-
tein (Simon and Green, 1985). Involucrin was also shown
to promote the cross-linking of the particulate fraction
containing membrane proteins. In other respects, involu-
crin is thought suitable as a protein able to cross-link other
proteins (Yaffe et al., 1992). Involucrin is rich in glutamine
residues (Djian et al., 1993; Eckert and Green, 1986), a
property in keeping with its function as an amine acceptor
in transglutaminase-catalyzed cross-linking; other enve-
lope precursors, such as loricrin, envoplakin, periplakin, or
the small proline-rich proteins, are not glutamine-rich. For
all of these reasons, it is surprising that envelopes should
form normally in mice lacking involucrin. The presence of
Figure 5. Cornified cell envelopes of mice lacking involucrin. En-
velopes were prepared from ear skin incubated in the presence of
SDS and DTT at 1008C. (A) inv2/2. (B) inv1/1. There is no clear
difference between the two. The ratio of angular to balloon forms
was not consistently different. Bar, 50 mm.
Figure 6. Northern blot analysis showing envelope precursor
mRNA levels in mice lacking involucrin and wild-type mice. Ab-
sence of involucrin is not compensated by increased levels of the
mRNAs encoding SPRR1 or loricrin.The Journal of Cell Biology, Volume 151, 2000 386
these cross-linked envelopes in inv2/2 mice clearly estab-
lishes that contrary to earlier suggestions (Steinert and
Marekov, 1997), whatever properties might be conferred
on envelopes by involucrin, this protein is not essential for
the assembly of envelopes, which in its absence consist ex-
clusively of other proteins.
It remains to be seen whether more detailed examina-
tion of the skin of inv2/2 mice will reveal a detectable dif-
ference from that of wild-type mice. We have provided the
inv2/2 mice to Dr. Peter Elias (University of California at
San Francisco, San Francisco, CA) and to Drs. M. Jensen
and E. Proksch (University of Kiel, Kiel, Germany) for de-
tailed examination of the water vapor barrier and ultra-
structural studies of the envelopes.
The disruption of the loricrin gene, which encodes an-
other envelope precursor (Mehrel et al., 1990), also does
not prevent envelope assembly, although it results in tran-
sitory redness of skin immediately after birth (Koch et al.,
2000, this issue). It seems that whereas the transglutami-
nase is required in order to make the cross-linked enve-
lope, neither involucrin nor loricrin is individually re-
quired. Mutations in the COOH-terminal part of human
loricrin cause Vohwinkel syndrome, but the mutated al-
leles are dominant and the disease is likely to result from a
gain of function (Maestrini et al., 1996).
The involucrin gene of the mouse is very polymorphic
and this in itself would be compatible with the absence of
strong selective pressure. However, this polymorphism in-
cludes the addition of numerous repeats that increase the
size of the protein from 448 to 695 residues (Delhomme
and Djian, 2000). The involucrins of the BALB/c and
C57BL/6 strains used in this study contain 448 and 468 res-
idues, respectively. It is therefore necessary to suppose ei-
ther that the increases in size occur in the absence of any
demonstrated necessity for the protein, or that evolution-
ary development of a larger involucrin will eventually ren-
der the protein indispensable.
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